Načítá se...
Clinical Trial Transparency Is Up for Grabs: The FDA and Congress Are Expanding Public Access to Data
Years of complaints about poor access to information on “compassionate use” of experimental drugs and a lack of transparency in clinical trials are driving reform efforts by the National Library of Medicine, the Food and Drug Administration, and Congress.
Uloženo v:
| Vydáno v: | P T |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MediMedia USA, Inc.
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4495870/ https://ncbi.nlm.nih.gov/pubmed/26185404 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|